how to verify peptide purity before buying.

Peptide purity is not a marketing claim - it is a measurable, analytically verifiable property of a research compound. For laboratories conducting in vitro studies, purity directly affects the reproducibility and interpretability of experimental results. A compound supplied at 85% purity contains 15% unknown material: degradation products, synthesis by-products, residual reagents, or structurally similar sequences with different biological activity. In any quantitative assay, that 15% introduces unmeasured variables.

This is why rigorous research institutions apply specific quality thresholds before procuring peptides. Understanding how purity is measured, what the reported figures mean, and how to evaluate a Certificate of Analysis (CoA) independently is an essential skill for any laboratory researcher sourcing peptides for scientific work.

BodyPharm UAE supplies batch-specific Certificates of Analysis with every research compound. You can review CoA documentation for current batches before ordering: BPC-157 + TB-500 lab results, Retatrutide lab results, GHK-Cu lab results, and CJC-1295 + Ipamorelin lab results.

High-Performance Liquid Chromatography (HPLC)

HPLC is the standard analytical technique for determining peptide purity. The method works by dissolving the compound in a mobile phase and passing it through a column packed with a stationary phase material. Different molecular species travel through the column at different rates depending on their chemical properties - hydrophobicity, charge, and molecular size - and are detected as they elute from the column, typically using ultraviolet (UV) absorbance at 214nm or 220nm (wavelengths that detect peptide bonds).

The resulting output is a chromatogram: a graph plotting detector signal against time. Each peak represents a distinct molecular species. The target peptide should appear as the dominant peak. The purity percentage reported on a CoA represents the area of the target peak as a proportion of total peak area across the chromatogram. A purity of 98% means 98% of the detected material elutes with the expected retention time for the target compound, with 2% attributable to other species.

What constitutes acceptable purity depends on the research application:

• 98%+ purity is the pharmaceutical-grade standard and is appropriate for research requiring precise quantitative interpretation. This is the threshold BodyPharm UAE targets for all supplied compounds.
• 95-97% purity may be acceptable for preliminary screening assays where absolute quantitative precision is less critical.
• Below 95% purity is generally considered research-grade only for very early-stage exploratory work and is not suitable for dose-response studies, mechanistic assays, or publication-quality data generation.

HPLC alone, however, tells you what proportion of the material elutes at the expected time - it does not confirm that this material is actually the peptide you ordered. A structurally similar contaminant with the same retention time would not be detected by HPLC purity measurement alone.

Mass Spectrometry (MS)

Mass spectrometry addresses the limitation of HPLC by providing molecular identity confirmation. The technique measures the mass-to-charge ratio of ionised molecules, producing a spectrum that reveals the molecular weight of the compound present in the sample.

Every peptide has a defined molecular weight determined by its amino acid sequence. For example, BPC-157 (a 15-amino acid sequence) has a molecular weight of approximately 1,419.5 Da. If a mass spectrometry analysis of a supplied compound returns a molecular ion peak consistent with this value, researchers can be confident they have the correct peptide - not a truncated sequence, a scrambled analogue, or a structural isomer.

The combination of HPLC and MS is the gold standard for research-grade peptide verification. HPLC confirms purity; mass spectrometry confirms identity. A CoA that reports both is materially more informative than one reporting either method in isolation.

Some suppliers use HPLC-MS (liquid chromatography coupled with mass spectrometry) as an integrated technique, which provides simultaneous purity and identity data. This is the highest-quality verification method available for research peptide qualification.

A Certificate of Analysis (CoA) is a formal document issued by a testing laboratory attesting to the analytical results for a specific batch of a compound. Knowing how to read a CoA allows researchers to evaluate the quality of a peptide independently, rather than relying solely on a supplier's claims.

Key Elements of a Valid CoA

In-house testing - where the supplier conducts their own quality analysis - creates an obvious conflict of interest. A supplier testing their own product has both the technical capability and commercial incentive to present favourable results. This does not mean all in-house testing is fraudulent, but it does mean researchers cannot independently verify that the stated methods were applied correctly, that the equipment was properly calibrated, or that the results were accurately transcribed.

Third-party testing by an independent analytical laboratory eliminates this conflict. The testing facility has no commercial relationship with the product outcome and applies standardised analytical protocols that can, in principle, be reproduced by any other qualified laboratory.

Janoshik Analytical: An Established Third-Party Reference

Janoshik Analytical is a third-party testing laboratory widely used within the research peptide supply industry for independent quality verification. Janoshik conducts HPLC purity analysis and mass spectrometry identity confirmation for peptide compounds, issuing publicly accessible certificates that can be verified through a unique certificate number on their website.

The public accessibility of Janoshik certificates is a meaningful transparency feature. A researcher can independently look up a certificate number and confirm the results were genuinely issued by the laboratory, rather than accepting a supplier-provided document at face value. This verification capability is not available with in-house testing or with third-party labs that do not publish results publicly.

BodyPharm UAE uses independent third-party testing for quality verification. Batch-specific CoA documents are available for review at Retatrutide, BPC-157 + TB-500, GHK-Cu, and CJC-1295 + Ipamorelin.

Not all research peptide suppliers apply the same quality standards. Recognising red flags in supplier documentation and marketing allows researchers to avoid wasting research budgets on unreliable compounds - or worse, contaminating their data with impure material of unknown composition.

No Certificate of Analysis Available

A supplier unable or unwilling to provide a CoA for their products is offering research compounds with no documented quality verification. There is no basis for a researcher to assume the compound is what the label states, at any purity level. This is the most fundamental red flag in research peptide procurement.

Generic CoA Not Tied to a Specific Batch

A CoA without a batch number, or a CoA that uses generic placeholder language rather than specific analytical results, is not a meaningful quality document. Batch-specific testing confirms that the actual product in the vial was tested - not a representative sample from a different production run, or a fabricated document.

In-House Testing Only, No Third-Party Verification

Suppliers who conduct all testing internally and do not provide access to independent laboratory results cannot offer the same level of analytical confidence as those using accredited third-party laboratories. This does not automatically indicate fraud, but it does mean the researcher has no independent means of verifying the stated results.

HPLC Results Without Mass Spectrometry

A CoA reporting HPLC purity only - without mass spectrometry data - confirms the proportion of material eluting at a given retention time but does not confirm molecular identity. Purity without identity verification is an incomplete quality picture for research applications.

Purity Claims Without Stated Analytical Method

A purity percentage stated without specifying the analytical technique (HPLC, GC, titration, etc.) cannot be independently evaluated. Different methods measure different things, and not all are appropriate for peptide purity determination. HPLC by UV or HPLC-MS are the accepted standard methods; other techniques without justification are a flag for further scrutiny.

No Information on Storage and Stability

Legitimate research peptide suppliers provide storage recommendations and stability information because peptide integrity is time- and condition-dependent. Suppliers who provide no handling or storage guidance may not be working with materials maintained under appropriate conditions during their own storage and shipping.

Scientific reproducibility - the ability of independent researchers to obtain consistent results using the same experimental conditions - is a foundational requirement of valid research. When a research peptide contains impurities, two separate experiments using nominally the same compound may produce different results if the impurity composition varies between batches.

This issue is particularly acute in dose-response studies, where the relationship between compound concentration and observed effect is the primary experimental variable. If 5% of the material in a preparation is an unknown by-product with its own biological activity, the effective concentration of the target peptide is not what the researcher calculates from the stated quantity. The dose-response curve shifts in an unknown direction by an unknown amount.

For research intended for publication, peer reviewers increasingly scrutinise compound quality documentation. Many journals in the peptide and pharmacology literature now request or recommend disclosure of compound purity verification as part of methods sections. Researchers who have sourced from suppliers with batch-specific, third-party-verified CoAs are better positioned to satisfy these requirements than those relying on unverified compounds.

BodyPharm UAE supplies all research peptides with batch-specific Certificates of Analysis. CoA documents for current batches are published and publicly accessible before purchase, so researchers can review quality data as part of their procurement decision rather than after receiving an order.

Lab results pages for each compound are available at:

• Retatrutide 32mg - Lab Results and CoA
• BPC-157 + TB-500 - Lab Results and CoA
• GHK-Cu 50mg - Lab Results and CoA
• CJC-1295 + Ipamorelin - Lab Results and CoA

Each document includes the batch number, test date, HPLC purity result, mass spectrometry molecular weight confirmation, and the testing laboratory reference. Researchers can cross-reference batch numbers on received vials against published CoA documents to confirm the specific lot tested. View the full BodyPharm UAE product catalogue for all currently available research compounds.

What does 98% purity mean for a research peptide?

A purity of 98% as measured by HPLC means that 98% of the detected material in the sample elutes with the expected retention time for the target peptide. The remaining 2% represents other species - which may include synthesis by-products, degradation products, or residual reagents. Ninety-eight percent is the threshold widely considered pharmaceutical grade and is the standard BodyPharm UAE targets for all supplied research compounds.

Is HPLC the only method needed to verify peptide purity?

HPLC purity analysis confirms the proportion of the material that behaves like the target compound chromatographically, but it does not confirm molecular identity. Mass spectrometry is required to verify that the dominant peak in an HPLC chromatogram is actually the peptide stated on the label, not a structurally similar compound with the same retention time. Both methods together provide complete quality verification.

What is a batch-specific CoA and why does it matter?

A batch-specific Certificate of Analysis is a testing document tied to a specific production lot - identified by a unique batch or lot number - of a compound. Because peptide synthesis and quality can vary between production runs, only batch-specific CoA documentation confirms that the product in the vial you receive was actually tested. Generic CoAs not linked to a specific batch number do not provide this assurance.

Who is Janoshik and why do they appear on peptide CoAs?

Janoshik Analytical is an independent third-party testing laboratory that conducts HPLC purity and mass spectrometry analysis for research compounds. They publish test certificates publicly with unique reference numbers, allowing researchers to independently verify that a certificate is genuine rather than relying on a supplier-provided copy. Their use by a supplier is a positive indicator of third-party quality verification, as it removes the conflict of interest inherent in self-testing.

What should I check on a CoA before buying a research peptide?

At minimum, verify that the CoA includes a specific batch number matching the product, a test date, a purity percentage with stated analytical method, mass spectrometry data confirming molecular weight, and the name of the testing laboratory. If any of these elements are missing or generic, request clarification from the supplier before purchase.

Can I verify a Janoshik certificate independently?

Yes. Janoshik publishes test results on their website accessible by certificate number. If a supplier provides a Janoshik reference number with a CoA, researchers can independently look up that certificate to confirm the results were genuinely issued by the laboratory and match the document provided. This is a meaningful transparency feature not available with in-house testing programmes.

Does BodyPharm UAE provide CoAs before purchase?

Yes. BodyPharm UAE publishes batch-specific CoA documentation on dedicated lab results pages for each compound, accessible before ordering. This allows researchers to review quality data - including HPLC purity and mass spectrometry results - as part of their procurement evaluation. Links to each compound's lab results page are listed above.

Why does research peptide purity affect experimental reproducibility?

Impurities in a research compound introduce unmeasured variables into any assay. If a peptide preparation contains unknown by-products with biological activity of their own, observed experimental effects may not be attributable solely to the target compound. This can produce results that cannot be reproduced by other researchers using higher-purity material, undermining the scientific validity of the data. Consistent use of high-purity, batch-verified compounds is foundational to reproducible research.

All BodyPharm UAE products are supplied strictly for laboratory and in vitro research purposes only. They are not intended for human consumption, clinical administration, diagnosis, or treatment. Nothing in this article constitutes medical advice. Researchers should comply with all applicable institutional and regulatory requirements governing the procurement and use of research compounds.